Surmodics Stock Today
| SRDX Stock | USD 34.10 0.00 0.00% |
PerformanceVery Weak
| Odds Of DistressLow
|
SurModics is trading at 34.10 as of the 17th of February 2025; that is No Change since the beginning of the trading day. The stock's open price was 34.099998. SurModics has only a 8 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 18th of January 2025 and ending today, the 17th of February 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 4th of March 1998 | Category Healthcare | Classification Health Care |
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota. The company has 14.3 M outstanding shares of which 601.74 K shares are at this time shorted by private and institutional investors with about 1.79 trading days to cover. More on SurModics
Moving against SurModics Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
SurModics Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO and President and Director | Gary Maharaj | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsSurModics can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand SurModics' financial leverage. It provides some insight into what part of SurModics' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SurModics (SRDX) is traded on NASDAQ Exchange in USA. It is located in 9924 West 74th Street, Eden Prairie, MN, United States, 55344-3523 and employs 389 people. SurModics is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 487.49 M. SurModics conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 14.3 M outstanding shares of which 601.74 K shares are at this time shorted by private and institutional investors with about 1.79 trading days to cover.
SurModics currently holds about 22.09 M in cash with 248 K of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.58.
Check SurModics Probability Of Bankruptcy
Ownership AllocationThe market capitalization of SurModics is $487.49 Million. The majority of SurModics outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in SurModics to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in SurModics. Please pay attention to any change in the institutional holdings of SurModics as this could imply that something significant has changed or is about to change at the company. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check SurModics Ownership Details
SurModics Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Gardner Lewis Asset Management L P | 2024-12-31 | 262.9 K | |
| Hsbc Holdings Plc | 2024-09-30 | 247.5 K | |
| Beryl Capital Management Llc | 2024-12-31 | 237.6 K | |
| Disciplined Growth Investors Inc | 2024-12-31 | 229.6 K | |
| Goldman Sachs Group Inc | 2024-09-30 | 215.8 K | |
| Halcyon Management Partners Lp | 2024-12-31 | 187.9 K | |
| Oddo Bhf Asset Management Sas | 2024-09-30 | 170 K | |
| Gamco Investors, Inc. Et Al | 2024-12-31 | 143.9 K | |
| Eisler Capital (uk) Ltd. | 2024-09-30 | 136.4 K | |
| Blackrock Inc | 2024-09-30 | 1.2 M | |
| Alliancebernstein L.p. | 2024-09-30 | 1 M |
SurModics Historical Income Statement
SurModics Stock Against Markets
SurModics Corporate Management
| Charles Olson | Sr. VP and General Manager of Medical Device | Profile | |
| Timothy Arens | VP of Corporate Devel. and Strategy | Profile | |
| Joseph Stich | VP and General Manager of In-Vitro Diagnostics | Profile | |
| Gordon JD | General Legal | Profile | |
| Gordon Weber | General Legal | Profile |
Additional Tools for SurModics Stock Analysis
When running SurModics' price analysis, check to measure SurModics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SurModics is operating at the current time. Most of SurModics' value examination focuses on studying past and present price action to predict the probability of SurModics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SurModics' price. Additionally, you may evaluate how the addition of SurModics to your portfolios can decrease your overall portfolio volatility.